Pembrolizumab Plus Docetaxel and Prednisone in Patients With mCRPC
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
European Urology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Pembrolizumab Plus Docetaxel and Prednisone in Patients with Metastatic Castration-resistant Prostate Cancer: Long-term Results from the Phase 1b/2 KEYNOTE-365 Cohort B Study
Eur Urol 2022 Apr 06;[EPub Ahead of Print], EY Yu, MP Kolinsky, WR Berry, M Retz, L Mourey, JM Piulats, LJ Appleman, E Romano, G Gravis, H Gurney, M Bögemann, U Emmenegger, AM Joshua, M Linch, S Sridhar, HJ Conter, B Laguerre, C Massard, XT Li, C Schloss, CH Poehlein, JS de BonoFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.